NFKB1 and cancer: It has been demonstrated that vitamin K2 inhibits nuclear factor (NF)-κB activation by blocking the activities of protein kinase C (PKC)-α and ε kinases, which in turn prevents protein kinase D1 activation in cancer cells [139].